克雷门2通过激活EGFR/JAK2/STAT3信号通路来促进结直肠癌的进展
Xiaopei Xue1, Sumei Zhang1, Xu Sun2
1Department of Gastroenterology, Rugao Traditional Chinese Medicine Hospital, Rugao, China.
Iranian journal of biotechnology
|December 31, 2025
概括
克雷门2,一个Wnt/β-catenin通路调节器,在结直肠癌 (CRC) 中升高. 沉默Kremen2通过降低EGFR/JAK2/STAT3通路的调节来减少CRC细胞的增殖和迁移,从而将Kremen2确定为潜在的治疗标.
科学领域:
- 分子瘤学分子瘤学
- 癌症信号通路是癌症的信号通路.
背景情况:
- 克雷门2是一种Wnt/β-catenin信号通路调节器,与瘤发生有关.
- 它在结直肠癌 (CRC) 病原发生中的特定作用基本上是未知的.
研究的目的:
- 研究Kremen2在结直肠癌中的功能.
- 阐明Kremen2在癌细胞扩散和转移中的分子机制.
主要方法:
- 评估了人类结肠癌细胞系与正常细胞中的Kremen2表达.
- 创建了一个Kremen2敲击模式来评估对细胞增殖和迁移的影响.
- 在Kremen2抑制后分析了信号通路的改变.
主要成果:
- 在结肠癌细胞中,克雷门2的表达显著更高.
- 克雷门2倒置降低了癌细胞的活力和迁移.
- 制Kremen2导致EGFR/JAK2/STAT3通路的下调.
结论:
- 克雷门2通过EGFR/JAK2/STAT3激活促进结直肠癌细胞的增殖和迁移.
- 克雷门2代表了结直肠癌治疗的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K


